NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0478540623811426 |
0.35870205 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0478540623811426 |
0.13381793 |
NSC 134459 |
Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) |
0.0478540623811426 |
0.31934442 |
NSC 21683 |
Null |
0.0478540623811426 |
0.37452613 |
NSC 287069 |
Epicorazine A |
0.0478540623811426 |
0.20342488 |
NSC 31780 |
3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) |
0.0478540623811426 |
0.38009475 |
NSC 330507 |
Tanespimycin |
0.0478540623811426 |
0.63574918 |
NSC 346098 |
Null |
0.0478540623811426 |
0.46973515 |
NSC 361605 |
Uracil, 5-fluoro-1-[tetrahydro-5-oxo-3-(trimethylsiloxy)-2-furanyl]-, (2S,trans)- |
0.0478540623811426 |
0.18095022 |
NSC 372939 |
Null |
0.0478540623811426 |
0.47640154 |